Schranz Jennifer 4
4 · Nabriva Therapeutics plc · Filed Jul 2, 2020
Insider Transaction Report
Form 4
Schranz Jennifer
Chief Medical Officer
Transactions
- Tax Payment
Ordinary Shares
2020-06-30$0.67/sh−301$203→ 168,745 total
4 · Nabriva Therapeutics plc · Filed Jul 2, 2020
Ordinary Shares